H01
AssetAlso 4-methylumbelliferone, 4-MU
Inhibits hyaluronan synthesis to reduce inflammatory, fibrotic, and metabolic signaling.
- Stage
- Phase 2
- Modality
- Small molecule
- Target
- Not known
- 2
- Indications
- 0
- Trials
- 1
- Developer
Indications
2Interstitial lung disease
Phase 2, halobiosciences.com, 10 Oct 2026
Pulmonary hypertension
Phase 2, halobiosciences.com, 10 Oct 2026
In the full profile
- Owner and partners1
- Competitors4
Every asset’s record: target, stage, trials and the evidence behind it.